T. Srinivas et al. / Tetrahedron Letters xxx (2014) xxx–xxx
3
OH
1
2
OH
6
4
8
5
3
7
O
O
A
11
B
a
b
Figure 3. (a) NOESY spectrum (in CDCl3) of 11; (b) energy minimized structure of 11.
deprotection of acetonide group under acidic conditions with
Amberlyst9 led to the final target 1 (78%). The spectral data of
the target compound 1 was in fairly good agreement with that of
the isolated natural product (see SI).10 However, the optical rota-
25
tion of the synthetic 1 was found to be [
a
]
D
À6.83 (c 1.5, MeOH);
25
while that of Natural 1 was reported as: [
a
]
À2.72, (c 0.16,
D
MeOH).11Additionally, the purity of synthetic 1 was determined
by HPLC analysis {XCB C18 column; 4.6 Â 150 mm; 40% water
(NH4OAc 10 mm) in acetonitrile; 1 mL/min; 254 nm, tr(major) =
6.958, tr(minor) = 3.019} and found to be 97.2%.10 Similarly, com-
pound 1 (Fig. 3), on 1H–1H COSY and NOESY experiments, showed
the correlation between C3H/C5H, C5H/C7H and C6H/C7H,
confirming that the centre C5 assigned as ‘S’ was indeed correct
and the energy diagrams are also incorporated in the Supporting
information.
10. Spectral
data
of
selected
compounds:
(E)-1-((4S,5S)-5-(2-(4-
Methoxybenzyloxy)ethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)but-2-en-1-one (9).
25
[a
]
D
À14.23 (c 1.2, CHCl3); 1H NMR (300 MHz, CDCl3): d 7.24 (d, J = 8.6 Hz, 2H),
6.93–7.05 (m, 1H), d 6.87 (d, J = 8.6 Hz, 2H), 6.5 (dd, J = 1.7, 15.6 Hz, 1H), 4.52–
4.62 (m, 2H), 4.42 (s, 2H), 3.80 (s, 3H), 3.55 (q, J = 5.2, 7.3 Hz, 2H), 1.91 (dd,
J = 1.7, 6.9 Hz, 3H), 1.66–1.77 (m, 2H), 1.61 (s, 3H), 1.39 (s, 3H); 13C NMR
(75 MHz, CDCl3): d 197.2, 159.1, 144.5, 130.4, 127.5, 113.6, 113.7, 109.9, 81.7,
74.9, 72.6, 66.6, 55.2, 30.9, 27.1, 25.0,18.5; MS-ESI: m/z C19H26O5 [M+NH4]+:
352.
In summary, we have accomplished the first total synthesis of
catenioblin B (1) in 12 steps featuring a Sharpless epoxidation,
Ti(IV) promoted nucleophilic regioselective epoxide ring-opening
and intramolecular cyclization as the key reaction steps.
(S,E)-1-((4R,5S)-5-(2-(4-Methoxybenzyloxy)ethyl)-2,2-dimethyl-1,3-dioxolan-4-
yl)but-2-en-1-ol (10). [
a
]
D
À8.3 (c 0.5, CHCl3); 1H NMR (300 MHz, CDCl3): d
25
Acknowledgments
7.26 (d, J = 8.6 Hz, 2H), 6.88 (d, J = 8.6 Hz, 2H), 5.71–5.84 (m, 1H), 5.45 (dddd,
J = 1.5, 7.1, 15.48 Hz, 1H), 4.4 (s, 2H), 4.30 (q, J = 6.0, 13.5 Hz, 1H), 4.09 (br s,
1H), 3.96 (t, J = 6.0 Hz, 1H), 3.81 (s, 3H), 3.55–3.61 (m, 2H), 2.35 (br s, 1H),
1.85–1.90 (m, 2H), d 1.71 (d, J = 6.4 Hz, 3H), 1.49 (s, 3H), 1.37 (s, 3H); 13C NMR
(125 MHz, CDCl3): d 159.1, 129.8, 129.2, 113.7, 107.9, 80.2, 74.2, 72.7, 70.7,
67.1, 55.2, 30.2, 25.3, 27.7, 17.9; MS-ESI: m/z C19H28O5 [M+NH4]+: 335.
One of the authors (T.S.) is thankful to the IICT-RMIT Research
Programme (CLP-0092) for the financial support in the form of
research fellowship. The authors are thankful to the respective
Program Directors Dr. M. Lakshmi Kantam (IICT) and Prof. Suresh
Bhargava (RMIT) for the generous support and encouragement.
(S,E)-1-((4R,5S)-5-(2-Hydroxyethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)but-2-en-1-
À12.9 (c 0.5, CHCl3); 1H NMR (300 MHz, CDCl3): 5.77–5.90 (m,
25
ol (11). [
a
]
D
1H), 5.46 (ddd, J = 1.5, 6.7, 15.1 Hz, 1H), 4.29–4.36 (m, 1H), 4.11 (t, J = 6.7 Hz,
1H), 4.01 (t, J = 6.0 Hz, 1H), 3.80–3.85 (m, 2H), 2.37 (br s, 1H), 1.86–1.99 (m,
2H), d 1.73 (d, J = 6.0 Hz, 3H), 1.52 (s, 3H), 1.38 (s, 3H); 13C NMR (75 MHz,
CDCl3): d 130.3, 129.5, 108.4, 80.4, 76.1, 70.7, 61.1, 32.1, 27.8, 25.4, 17.9; MS-
ESI: m/z C11H20O4 [M+Na]+: 239.
Supplementary data
Supplementary data associated with this article can be found, in
(3aS,4S,7aS)-2,2-Dimethyl-4-((E)-prop-1-enyl)dihydro-3aH-[1,3]dioxolo[4,5-
25
c]pyran-6(4H)-one (12). [
a
]
D
À12.43 (c 1.8, CHCl3); 1H NMR (300 MHz, CDCl3):
5.87–5.93 (m, 1H), 5.72 (ddd, J = 1.6, 7.7, 15.5 Hz, 1H), 4.70–4.73 (m, 1H), 4.48
(d, J = 7.7 Hz, 1H), 4.38 (dd, J = 1.8, 7.6 Hz, 1H), 2.88 (dd, J = 2.3, 15.8 Hz, 1H),
2.52 (dd, J = 3.6, 15.8 Hz, 1H), 1.78 (dd, J = 1.5, 6.4 Hz, 3H), 1.47 (s, 3H), 1.34 (s,
3H); 13C NMR (75 MHz, CDCl3): d 171.7, 132.1, 124.2, 109.4, 78.9, 74.7, 71.4,
34.5, 25.9, 24.1, 17.8; MS-ESI: m/z C11H16O4 [M+Na]+: 230.
References and notes
(4S,5S,6S)-4,5-dihydroxy-6-((E)-prop-1-enyl)tetrahydro-2H-pyran-2-one
(1).
25
[a
]
D
À6.83 (c 1.5, MeOH); 1H NMR (500 MHz, CDCl3): 5.83–5.87 (m, 1H),
5.60 (ddd, J = 1.5, 6.7, 15.1 Hz, 1H), 4.55–4.59 (m, 1H), 4.33 (t, J = 3.0 Hz, 1H),
4.25 (dd, J = 3.7, 6.7 Hz, 1H), 2.93 (dd, J = 6.7, 18.1 Hz, 1H), 2.51 (dd, J = 3.0,
18.1 Hz, 1H), 1.75 (d, J = 6.7 Hz, 3H); 13C NMR (125 MHz, CDCl3): d 175.3, 131.1,
128.1, 89.2, 72.6, 69.0, 38.1, 17.8; MS-ESI: m/z C8H12O4 [M+NH4]+:190.
11. In order to rationalize the differences in optical rotation values between the
synthetic 1 and Natural product 1, it was decided to record the same at
different concentrations for the synthetic 1. While, no specific rotation was
25
detected at c 0.16, only at c 0.7 it was detected as [
a
]
D
À6.95 (c 0.7, MeOH).
Since the reported value is very low, the difference in optical rotation values
between the two might be explained due to error in concentration and
temperature.